Jeremy Chataway

28PUBLICATIONS
155CO-AUTHORS
Gene and molecular therapyMolecular medicineProsthetics and orthoticsRegenerative medicine (incl. stem cells)Nanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 24, 2026
Developing Interim Outcome Measures for Multi-Arm Multistage Clinical Trials in Multiple Sclerosis.

|Jul 13, 2026
Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trial.

|Jun 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

|Dec 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial.

Kayla Ward, Vivien Li, Sudarshini Ramanathan

|Aug 07, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis.

Sarmad Al-Araji, Marcello Moccia, Ashwani Jha

|Sep 16, 2024
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.

James Blackstone, Thomas Williams, Jennifer M Nicholas

Pageof 5

Frequent Collaborators

5 joint publications

Floriana De Angelis

5 joint publications

Olga Ciccarelli

4 joint publications

Nevin John

4 joint publications

Ferran Prados Carrasco